Acquired Drug Resistance: Recognizing the Potential of Repurposed Drugs

Jan-Willem C Alffenaar^{1

2}, Vitali Sintchenko^{3

4

5}, Ben J Marais⁶

Affiliations

¹ University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia.
² Westmead Hospital, Sydney, Australia.
³ Centre for Infectious Diseases and Microbiology-Public Health, Westmead Hospital.
⁴ Sydney Medical School, The University of Sydney.
⁵ Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology.
⁶ The Children's Hospital at Westmead and the Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Australia.

Comment

Jan-Willem C Alffenaar et al. Clin Infect Dis. 2019.

. 2019 Nov 13;69(11):2038-2039.

doi: 10.1093/cid/ciz334.

Jan-Willem C Alffenaar^{1

2}, Vitali Sintchenko^{3

4

5}, Ben J Marais⁶

¹ University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia.
² Westmead Hospital, Sydney, Australia.
³ Centre for Infectious Diseases and Microbiology-Public Health, Westmead Hospital.
⁴ Sydney Medical School, The University of Sydney.
⁵ Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology.
⁶ The Children's Hospital at Westmead and the Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Australia.

No abstract available

Comment on

Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.
Polsfuss S, Hofmann-Thiel S, Merker M, Krieger D, Niemann S, Rüssmann H, Schönfeld N, Hoffmann H, Kranzer K. Polsfuss S, et al. Clin Infect Dis. 2019 Sep 13;69(7):1229-1231. doi: 10.1093/cid/ciz074. Clin Infect Dis. 2019. PMID: 30933266